Pregnancy complications such as gestational diabetes mellitus (GDM), preeclampsia, and gestational hypertensive disorders are becoming increasingly ...

The company reported its second late-stage study success, this time with a drug that could become a new treatment standard ...

Adolescents and young adults with preexisting autoimmune disease are more likely to develop type 1 diabetes than those ...

Based on the DESTINY-Breast06 phase III trial results demonstrating statistically significant and clinically meaningful progression-free survival benefit in patients treated with Enhertu vs.

The obesity rate for adults in the U.S. dropped to 37% in 2025 after peaking at 39.9% in 2022, but diabetes has reached an ...

From the "pot-bellied" appearance to the flaws in the LDDST, Cushing's disease remains one of our most complex endocrine ...

Lipid biomarkers, including common measures such as cholesterol and triglycerides as well as newer indicators like lipoproteins, apolipoproteins, and ...

Researchers present an overview of treatment and management strategies for patients with HR+/HER2+ breast cancer, including common adverse effects.

Eton Pharmaceuticals (ETON) leads rare-disease markets. Valuation is stretched, trading at a significant premium vs. peers.

Endogenous Cushing's syndrome is a severe, potentially lethal, endocrine condition. It is well known for its pleomorphic clinical manifestations that often overlap with those of frequent endocrine and ...

Sponsored by LSU’s Pennington Biomedical Research Center For many living with diabetes or many other endocrine related ...

Verzenio plus endocrine therapy reduced death risk by 15.8% in high-risk early breast cancer patients compared to endocrine ...